Department of Orthopedics, Xianyang Central Hospital, Xianyang, 712000, China.
Clinical Medical Research Center, Xianyang Central Hospital, Xianyang, 712000, China.
Eur Spine J. 2022 May;31(5):1108-1121. doi: 10.1007/s00586-021-07064-z. Epub 2021 Nov 25.
The aim of this work was to investigate the risk factors for cement leakage and new-onset OVCF after Percutaneous vertebroplasty (PVP) and to develop and validate a clinical prediction model (Nomogram).
Patients with Osteoporotic VCF (OVCF) treated with PVP at Liuzhou People's Hospital from June 2016 to June 2018 were reviewed and met the inclusion criteria. Relevant data affecting bone cement leakage and new onset of OVCF were collected. Predictors were screened using univariate and multi-factor logistic analysis to construct Nomogram and web calculators. The consistency of the prediction models was assessed using calibration plots, and their predictive power was assessed by tenfold cross-validation. Clinical value was assessed using Decision curve analysis (DCA) and clinical impact plots.
Higher BMI was associated with lower bone mineral density (BMD). Higher BMI, lower BMD, multiple vertebral fractures, no previous anti-osteoporosis treatment, and steroid use were independent risk factors for new vertebral fractures. Cement injection volume, time to surgery, and multiple vertebral fractures were risk factors for cement leakage after PVP. The development and validation of the Nomogram also demonstrated the predictive ability and clinical value of the model.
The established Nomogram and web calculator (https://dr-lee.shinyapps.io/RefractureApp/) (https://dr-lee.shinyapps.io/LeakageApp/) can effectively predict the occurrence of cement leakage and new OVCF after PVP.
本研究旨在探讨经皮椎体成形术(PVP)后骨水泥渗漏和新发椎体骨折(OVCF)的危险因素,并建立和验证临床预测模型(诺莫图)。
回顾性分析 2016 年 6 月至 2018 年 6 月在柳州市人民医院接受 PVP 治疗的骨质疏松性椎体压缩骨折(OVCF)患者,纳入标准为符合骨质疏松性椎体压缩骨折的诊断标准,行单侧或双侧经皮穿刺骨水泥椎体成形术或后凸成形术治疗,且术前、术后均有 X 线或 CT 等影像学资料证实。收集患者的一般资料、临床特征、影像学资料、实验室检查等,分析影响骨水泥渗漏和新发 OVCF 的相关因素。采用单因素和多因素 Logistic 回归分析筛选预测因子,建立诺莫图和网络计算器。采用校准图评估预测模型的一致性,采用 10 折交叉验证评估预测模型的准确性。采用决策曲线分析(DCA)和临床影响图评估预测模型的临床价值。
BMI 与骨密度呈负相关,BMI 较高的患者骨密度较低。较高的 BMI、较低的骨密度、多发椎体骨折、无抗骨质疏松治疗史和使用激素是新发椎体骨折的独立危险因素。骨水泥注射量、手术时间和多发椎体骨折是 PVP 后骨水泥渗漏的危险因素。诺莫图的开发和验证也表明了该模型的预测能力和临床价值。
本研究建立的诺莫图和网络计算器(https://dr-lee.shinyapps.io/RefractureApp/)(https://dr-lee.shinyapps.io/LeakageApp/)可有效预测 PVP 后骨水泥渗漏和新发 OVCF 的发生。